Completed
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
NCT02437370
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +19 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States